Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Aug;122(3):859-65.
doi: 10.1007/s10549-010-0732-3. Epub 2010 Jan 14.

Medical comorbidities predict mortality in women with a history of early stage breast cancer

Ruth E Patterson  1 , Shirley W Flatt, Nazmus Saquib, Cheryl L Rock, Bette J Caan, Barbara A Parker, Gail A Laughlin, Kirsten Erickson, Cynthia A Thomson, Wayne A Bardwell, Richard A Hajek, John P Pierce
Affiliations
Multicenter Study

Medical comorbidities predict mortality in women with a history of early stage breast cancer

Ruth E Patterson et al. Breast Cancer Res Treat. 2010 Aug.

Abstract

This analysis was conducted to determine whether comorbid medical conditions predict additional breast cancer events and all-cause mortality in women with a history of early stage breast cancer. Women (n = 2,542) participating in a randomized diet trial completed a self-administered questionnaire regarding whether they were currently being treated for a wide variety of diseases (cardiovascular, diabetes, gallbladder, gastrointestinal, arthritis, and osteoporosis) and conditions (high blood pressure, elevated cholesterol level). Height and weight were measured at baseline. Participants were followed for a median of 7.3 years (range 0.8-15.0). Cox regression analysis was performed to assess whether comorbidities predicted disease-free and overall survival; hazard ratio (HR) was the measure of association. Overall, there were 406 additional breast cancer events and 242 deaths. Participants with diabetes had over twofold the risk of additional breast cancer events (HR 2.1, 95% CI: 1.3, 3.4) and mortality (HR 2.5, 95% CI: 1.4, 4.4). The presence of multiple comorbidities did not statistically significantly predict additional breast cancer events. However, compared to no comorbidities, participants with 3 or more comorbidities had a HR of 2.1, 95% CI: 1.3, 3.3 for mortality. In conclusion, type 2 diabetes is associated with poor breast cancer prognosis. Given that 85% of deaths were caused by breast cancer, these findings suggest that multiple comorbidities may reduce the likelihood of surviving additional breast cancer events.

PubMed Disclaimer

References

    1. Ries L, Eisner M. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-Je, editors. Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, SEER Program; 1988–2001. NIH Pub. No. 07-6215; 2007.
    1. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009;124(5):1213–1219. - PubMed
    1. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. Increased prevalence of prior breast cancer in women with newly diagnosed diabetes. Breast Cancer Res Treat. 2006;98(3):303–309. - PubMed
    1. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. Jama. 2001;285(7):885–892. - PubMed
    1. Jee SH, Kim HJ, Lee J. Obesity, insulin resistance and cancer risk. Yonsei Med J. 2005;46(4):449–455. - PMC - PubMed

Publication types